Oncotelic Therapeutics, Inc. Debt Conversion, Converted Instrument, Amount
Oncotelic Therapeutics, Inc. (OTLC) reported Debt Conversion, Converted Instrument, Amount of $150.00 thousand for the 12-month period ending 2025-12-31, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2026-08-13
- Oncotelic Therapeutics, Inc. debt conversion, converted instrument, amount for the quarter ending 2025-12-31 was $88.00K.
- Oncotelic Therapeutics, Inc. debt conversion, converted instrument, amount for the quarter ending 2023-12-31 was $48.00K.
- Oncotelic Therapeutics, Inc. debt conversion, converted instrument, amount for the quarter ending 2023-09-30 was $0.00.
- Oncotelic Therapeutics, Inc. debt conversion, converted instrument, amount for the quarter ending 2023-06-30 was $0.00.
- Oncotelic Therapeutics, Inc. debt conversion, converted instrument, amount for fiscal 2024 was $35.00K, a 60.23% decline from fiscal 2023.
- Oncotelic Therapeutics, Inc. debt conversion, converted instrument, amount for fiscal 2023 was $88.00K.
- Oncotelic Therapeutics, Inc. debt conversion, converted instrument, amount for fiscal 2021 was $210.30K, a 80.41% decline from fiscal 2020.
- Oncotelic Therapeutics, Inc. debt conversion, converted instrument, amount for fiscal 2020 was $1.07M.
| Period end | Debt Conversion, Converted Instrument, Amount 1 month | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $88.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-13 | $150.00K 10-Q · filed 2026-08-13 | |||
| 2025-09-30 | $44.00K 10-Q · filed 2025-11-17 | $62.00K 10-Q · filed 2025-11-17 | |||
| 2025-06-30 | $32.00K 10-Q · filed 2025-08-13 | ||||
| 2025-03-31 | $32.00K 10-Q · filed 2025-05-15 | ||||
| 2024-12-31 | $35.00K 10-K · filed 2025-04-15 | ||||
| 2024-02-29 | $35.00K 10-Q · filed 2024-11-19 | ||||
| 2023-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-12 | $48.00K derived: sum of 2 quarters · filed 2024-04-12 | $48.00K derived: sum of 3 quarters · filed 2024-04-12 | $88.00K 10-K · filed 2024-04-12 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $40.00K 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-18 | $40.00K 10-Q · filed 2023-08-18 | |||
| 2023-03-31 | $40.00K 10-Q · filed 2023-05-22 | ||||
| 2021-12-31 | $210.30K 10-K · filed 2022-04-15 | ||||
| 2021-03-31 | $210.30K 10-Q · filed 2022-05-23 | ||||
| 2020-12-31 | $1.07M 10-K · filed 2022-04-15 | ||||
| 2020-09-30 | $76.06K 10-Q · filed 2021-11-22 | $179.50K derived: sum of 2 quarters · filed 2021-11-22 | $900.57K derived: sum of 3 quarters · filed 2021-11-22 | ||
| 2020-06-30 | $103.44K 10-Q · filed 2021-11-22 | $824.50K derived: sum of 2 quarters · filed 2021-11-22 | |||
| 2020-03-31 | $721.06K 10-Q · filed 2021-11-22 |